This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,104.30 firm fixed price delivery order is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, a pharmaceutical product. The contract has an ultimate completion date of October 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,619.10 firm fixed-price delivery order is for the supply of TUBERSOL 5T UNIT/0.1 ML VIALML, with a completion date of September 9, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen is the prime contractor and holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $5,502.31 firm fixed price delivery order is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML medical products. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award, with ID SPE2DB20D1050|SPE2DB24FH72Y, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,619.10 fixed-price delivery order is for the supply of TUBERSOL 5T UNIT/0.1 ML VIALML, a medical product, with a completion date of June 17, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award is for the delivery of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML medical supplies, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The $4,190.60 firm fixed-price contract, awarded on December 11, 2024, has a completion date of December 12, 2024. The contract is structured as a delivery order, without any set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor on this award, which is associated with the...
This federal contract award is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical distribution company. The award, valued at $2,104.30, is for the delivery of Tubersol 5T Unit/0.1 ML Vial 5ML, a pharmaceutical product, with a completion date of February 13, 2024. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.55 firm fixed-price delivery order is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, a medical product. The award is not associated with a set-aside program and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
This federal contract award is a delivery order (SPE2DB24FWT45) issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TUBERSOL 5T UNIT/0.1 ML VIALML. The contract has a ceiling value of $4,572.56 and is a firm fixed price type. It is not designated as a set-aside contract. The award date is August 23, 2024, and the ultimate completion date is August 26, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,710.88, is for the supply of Tubersol 5T Unit/0.1 ML Vial ML, a tuberculosis test product. The contract is a firm fixed-price delivery order, with an ultimate completion date of July 18, 2024. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp, through its Corporate Office Division, has been...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,936.44 firm fixed-price Delivery Order is for the supply of 4,558,011,045 units of APLISOL 5T, a 0.1 ML vial medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...